Who is sponsoring NCT03220308?

NCT03220308 is sponsored by Karakter Kinder- en Jeugdpsychiatrie.

What drugs are being tested in NCT03220308?

Interventions in NCT03220308: MYmind mindfulness training, Care-as-usual for children (8-16 years old) with ADHD.

What condition does NCT03220308 study?

NCT03220308 studies Attention Deficit Hyperactivity Disorder.

Is NCT03220308 still recruiting?

NCT03220308 is currently completed. Last updated 7 March 2019.

Last reviewed 2019-03-07 · How we verify

NCT03220308: MindChamp

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mindfulness Training for Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Mindful Parenting

Completed NA Last updated 7 March 2019

What this trial tests

NA trial testing MYmind mindfulness training in Attention Deficit Hyperactivity Disorder in 103 participants. Completed in 22 February 2019.

Timeline

18 February 2016

Primary endpoint
26 July 2018

22 February 2019

Quick facts

Lead sponsor	Karakter Kinder- en Jeugdpsychiatrie
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	103
Start date	18 February 2016
Primary completion	26 July 2018
Estimated completion	22 February 2019
Sites	3 locations across Netherlands

Drugs / interventions tested

MYmind mindfulness training
Care-as-usual for children (8-16 years old) with ADHD

Conditions studied

Attention Deficit Hyperactivity Disorder — all drugs for Attention Deficit Hyperactivity Disorder →

Sponsor

Karakter Kinder- en Jeugdpsychiatrie

Who can join

Adults 8 to 16, any sex, with Attention Deficit Hyperactivity Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the effectiveness of an 8-week mindfulness group training for children (8-16 years old) with ADHD in combination with a parallel mindful parenting training for their parents. Half of the participants will be randomly assigned to the mindfulness training in addition to care-as-usual (CAU); the other half to CAU-only. The hypothesis is that compared to care-as-usual only, the addition of the mindfulness training will improve self-control of youth with ADHD.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Individual participant data systematic review and meta-analysis of randomised controlled trials assessing adult mindfulness-based programmes for mental health promotion in non-clinical settings.
Galante J, Friedrich C, Collaboration of Mindfulness Trials (CoMinT) 3, Dalgleish T, et al · · 2023 · cited 45× · PMID 37867573 · DOI 10.1038/s44220-023-00081-5
A randomised controlled trial (MindChamp) of a mindfulness-based intervention for children with ADHD and their parents.
Siebelink NM, Bögels SM, Speckens AEM, Dammers JT, et al · · 2022 · cited 29× · PMID 34030214 · DOI 10.1111/jcpp.13430
Mindfulness for children with ADHD and Mindful Parenting (MindChamp): Protocol of a randomised controlled trial comparing a family Mindfulness-Based Intervention as an add-on to care-as-usual with care-as-usual only.
Siebelink NM, Bögels SM, Boerboom LM, de Waal N, et al · · 2018 · cited 11× · PMID 30045714 · DOI 10.1186/s12888-018-1811-y

Verify or expand the search:

Other recruiting trials for Attention Deficit Hyperactivity Disorder

Currently open trials in the same condition.

NCT07001475 — A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperact · Phase 1 · recruiting
NCT06847165 — Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure · NA · recruiting
NCT06325813 — ADHD PreSMA Response Inhibition Therapy · NA · recruiting
NCT06248229 — A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder · Phase 4 · recruiting
NCT06232226 — Attention Deficit Hyperactivity Disorder · NA · recruiting

Other Karakter Kinder- en Jeugdpsychiatrie trials

Trials by the same sponsor.

NCT06792227 — Family-Based Treatment at Home in Adolescents With Eating Disorders and Co-occurring Mental Health Conditions · NA · enrolling by invitation
NCT05987735 — Psycho-education Program BLAME-LESS and It's Effect on Traumarelated Shame and Guilt · NA · enrolling by invitation
NCT05547334 — IBA Treatment in Adolescents With OCD · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03220308 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Karakter Kinder- en Jeugdpsychiatrie
Last refreshed: 7 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03220308.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing